Xavier Maldonado

Has grant

Head of Department

Hospital Universitari Vall d'Hebron

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Imaging Medical Imaging professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Xavier Maldonado is the Head of Department at Hospital Universitari Vall d'Hebron in Spain. His research primarily focuses on prostate cancer, with recent articles addressing topics such as the efficacy and safety of radiotherapy, next-generation sequencing, and the integration of androgen deprivation therapy in treatment strategies. He is actively involved in exploring innovative approaches to manage high-risk prostate cancer and optimizing clinical outcomes for patients.

Recent Grants

Grant: Close

Estudio de los factores clínicos y biológicos asociados con el riesgo de recaída en cáncer de próstata localizado de riesgo intermedio y alto sometido a privación androgénica y radioterapia combinada

Open Date: 2024-12-01

Close Date: 2024-12-01

Grant: Open

Papel de los exosomas circulantes como biomarcador para la estratificación de riesgo y personalización del tratamiento en pacientes con cáncer de próstata postprostatectomía radical.

Open Date: 2023-11-01

Close Date: 2026-11-01

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Jie Deng

University of California, Los Angeles

UNITED STATES

View details

Gisela Mir Arnau

Vall d'Hebron Institute of Oncology

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xavier Maldonado

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence

Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial

Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel

A randomised trial of short‐ vs long‐term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06‐24

Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment

Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient

Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities

Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

Novel Approaches in the Systemic Management of High-Risk Prostate Cancer

Evaluation of Pulmonary Functions by Spirometry after Stereotactic Body Radiotherapy in Lung Tumors

Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.

Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials

Pineal germinoma in a young adult: A case report

Collaborators (2)

Jie Deng

Gisela Mir Arnau

Make your next move.